Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2000
11/08/2000EP1049718A1 Monoclonal antibody anti alphav-integrin and its use to inhibit alphavbeta6-integrin attachment to fibronectin
11/08/2000EP1049715A2 Rho family antagonists and their use to block inhibition of neurite outgrowth
11/08/2000EP1049714A1 Secreted proteins and polynucleotides encoding them
11/08/2000EP1049712A2 Hybrid tetanus toxoid proteins that migrate retrogradely and transynaptically into the cns
11/08/2000EP1049711A1 Liposomes comprising peptide antigens derived from x protein of hepatitis b virus
11/08/2000EP1049710A1 Peptides with beta-1 integrin subunit dependent cell adhesion modulating activity
11/08/2000EP1049709A1 Novel peptides having biological activity
11/08/2000EP1049708A1 Meth1 and meth2 polynucleotides and polypeptides
11/08/2000EP1049703A1 N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-l-aspartic acid aldehyde as an in vivo inhibitor of interleukin-1beta converting enzyme
11/08/2000EP1049673A1 Heterocyclic amidines as callicrein protease inhibitors
11/08/2000EP1049491A1 Gene therapy of tumors using non-viral delivery system
11/08/2000EP1049490A2 Method for inhibiting cd95-independent apoptosis in aids
11/08/2000EP1049488A1 METHOD OF AND COMPOSITIONS FOR IMMUNIZATION WITH THE $i(PSEUDOMONAS) V ANTIGEN
11/08/2000EP1049487A2 Method for treating acute intermittent porphyria (aip) and other porphyric diseases
11/08/2000EP1049486A1 Glp-1 formulations
11/08/2000EP1049485A1 Enhancement of hematopoietic cells
11/08/2000EP1049484A1 Method of using il-11 to enhance cell mediated immunity for treating various viral and parasitic infections and cancer
11/08/2000EP1049483A1 Method for treating inflammatory diseases using heat shock proteins
11/08/2000EP1049482A1 Method of producing elastin, elastin-based biomaterials and tropoelastin materials
11/08/2000EP1049481A2 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same
11/08/2000EP1049465A1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer
11/08/2000EP1049386A2 Process of improving the stability of vitamin d in a nutritional product containing hydrolyzed protein and product produced thereby
11/08/2000EP1030567A4 System, method and composition for dialysis and shock treatment
11/08/2000EP0975226A4 Cell-coated supports
11/08/2000EP0779806B1 Sustained release preparation containing metal salt of a peptide
11/08/2000EP0769006B1 Small molecule inhibitors of rotamase enzyme activity
11/08/2000EP0734396B1 ANALOGUES OF hGH-RH (1-29)NH2 HAVING ANTAGONISTIC ACTIVITY
11/08/2000EP0687180B1 Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/tyrosinase peptide antigens
11/08/2000EP0655089B1 Effects of actin filaments on fibrin clot structure and lysis
11/08/2000EP0652766B1 Human growth hormone aqueous formulation
11/08/2000EP0636029B1 Antibodies specific for carcinoma-associated antigens
11/08/2000EP0635132B1 Broadly reactive opsonic antibodies that react with common staphylococcal antigens
11/08/2000CN1272886A Polynucleotide encoding polypeptide having heparanase activity and expression of same in transduced cells
11/08/2000CN1272884A Adipocyte-specific protein homologs
11/08/2000CN1272883A Adipocyte-specific protein homologs
11/08/2000CN1272882A Chimeric polypeptide comprising fragment B of shiga toxin and peptides of therapeutic interest
11/08/2000CN1272840A Novel vitamin D derivatives with cyclopropyl rings in lateral chains, its production method and intermediate and utilization thereof for producing medicaments
11/08/2000CN1272792A Herbal extract composition and method with immune-boosting capability
11/08/2000CN1272784A Medicinal compositions for application to mucosa
11/07/2000US6143901 Complex formation between dsDNA and pyrrole imidazole polyamides
11/07/2000US6143886 Azepinone compounds useful in the inhibition of ACE and NEP
11/07/2000US6143878 Sox-9 gene and protein and use in the regeneration of bone or cartilage
11/07/2000US6143876 Immunogenic antigenic epitope which is a member of a binding couple; for production of antibodies with increased affinity; diagnosis; treatment; vaccines; viricides against human immunodeficiency virus
11/07/2000US6143875 Antibody to DNase involved in apoptosis
11/07/2000US6143874 Antibodies to the neurotrophic factor NNT-1
11/07/2000US6143873 Monoclonal anti-multiple drug resistance antibody, methods of production and uses thereof
11/07/2000US6143871 IL-13 and IL-4 binding polypeptides
11/07/2000US6143870 Thrombin receptor homolog
11/07/2000US6143869 CD30 ligand oligomers and polypeptides
11/07/2000US6143867 Amino acid sequence; for diagnosis, prevention, and treatment of late-phase allergic/inflammatory reactions, eosinophilias, parasitic infections, conditions associated with placental derived-basic protein accumulation in pregnancy
11/07/2000US6143866 Analog of a defined amino acid sequence; for treatment of septic shock and cachexia
11/07/2000US6143865 Amino acid sequences which are reactive with viral antibodies; for accurate and sensitive immunoassay diagnosis
11/07/2000US6143864 Peptides
11/07/2000US6143788 Bis-amino acid hydroxyethlamino sulfonamide retroviral protease inhibitors
11/07/2000US6143746 Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
11/07/2000US6143739 Antimicrobial agents mainly active against gram positive bacteria
11/07/2000US6143734 Nitroso esters of β-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs
11/07/2000US6143728 Guanylhydrazones useful for treating diseases associated with T cell activation
11/07/2000US6143723 Pigmentory agent
11/07/2000US6143722 To controll uterine contractions in treating preterm labor
11/07/2000US6143721 For treating cancer in mammals
11/07/2000US6143720 Lipocalin homologs
11/07/2000US6143719 Bradykinin analogs as selective thrombin inhibitors
11/07/2000US6143718 Treatment of Type II diabetes mellutis with amylin agonists
11/07/2000US6143717 Pharmaceutical composition and method for immunoenhancement therapy
11/07/2000US6143716 Liposomal peptide-lipid conjugates and delivery using same
11/07/2000US6143715 For treating and prevention of hepatitis c viurs infections
11/07/2000US6143714 Methods of using hepatocyte growth factor to promote survival, growth and differentiation of motor neurons
11/07/2000US6143544 Human lysophospholipase
11/07/2000US6143542 Nucleotide sequences that code an enzymatic protein; for detecting modulators of enzyme activity; for the prevention of insect infestation
11/07/2000US6143523 Nucleotide sequences coding somatotropin; for treatment of defect associated with reduction in somatotropin
11/07/2000US6143522 Activating programmed cell death in eukaryotic cells; amplifying theexpression of peptides or oligonucleotides associated with programmed cell death in eukaryotic cells
11/07/2000US6143521 Human bombesin receptor subtype-3sb
11/07/2000US6143519 Human endothelin-bombesin receptor
11/07/2000US6143501 Inducing artificial three-dimensional tissues using cell interaction systems such that cultures possessing or developing extracellular matrix are linked via membranes, or are in direct contact with or are mixed with each other
11/07/2000US6143491 Detecting insulin defect in humans; screening for adjustment in amino acid sequence
11/07/2000US6143306 Methods for treating pancreatic disorders
11/07/2000US6143305 Antigenically modified polypeptides composition
11/07/2000US6143299 Compositions and methods using complexes of heat shock protein gp96 and antigenic molecules for the treatment and prevention of infectious diseases
11/07/2000US6143298 Soluble truncated forms of ICAM-1
11/07/2000US6143296 Antibody 67D2
11/07/2000US6143295 Low molecular weight protein
11/07/2000US6143292 Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
11/07/2000US6143291 Methods for modulating T cell survival by modulating bcl-XL protein level
11/07/2000US6143290 Tumor regression by adenovirus expression of wild-type p53
11/07/2000US6143289 Compositions of myeloid-cell-suppressive chemokines
11/07/2000US6143275 Type S3 N2 chelators for radioactive isotopes, their metal complexes and their diagnostic and therapeutical use
11/07/2000US6143273 Useful as immunosuppressants, as well as antibodies capable of preventing the specific binding of the lag-3 protein to major histocompatibility complex class ii molecules as immunostimulants
11/07/2000US6143247 Affinity binding-based system for detecting particulates in a fluid
11/07/2000US6142972 Method and apparatus for the delivery of elongate solid drug compositions
11/07/2000CA2180657C Synthetic antimicrobial peptides
11/07/2000CA2166981C Oncoprotein protein kinase
11/07/2000CA2156455C Glycinamide derivatives, processes for their preparation and medicines containing them
11/07/2000CA2034100C A method of preparing a fibrinogen concentrate from blood plasma, a device for carrying out said method, and a method of preparing fibrinogen from said concentrate
11/07/2000CA2024767C Interferon-gamma receptor fragment and its production
11/03/2000CA2270360A1 A target for therapeutic reagents to stop the production of all forms of the abeta amyloid peptide (a.beta.) from the amyloid precursor protein (app) in humans
11/02/2000WO2000066152A1 A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor
11/02/2000WO2000065085A1 Interaction of vascular-endothelial protein-tyrosine phosphatase with the angiopoietin receptor tie-2
11/02/2000WO2000065067A2 Prostate-specific polynucleotides, polypeptides and their methods of use
11/02/2000WO2000065064A1 Peptides and assays for the diagnosis of lyme disease and compositions useful for the prevention thereof
1 ... 2328 2329 2330 2331 2332 2333 2334 2335 2336 2337 2338 2339 2340 2341 2342 2343 2344 2345 2346 2347 2348 ... 3163